Risk factor adapted treatment of Hodgkin's lymphoma in childhood: strategies and results of three consecutive multicenter studies in the Federal Republic of Germany.
Schellong
G
G
Abteilung für Hämatologie und Onkologie, Universitäts-Kinderklinik, Münster, FRG.
Hörnig
I
I
Schwarze
E W
EW
Wannenmacher
M
M
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005860:Germany, West; D006689:Hodgkin Disease / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D012307:Risk Factors; D014750:Vincristine / Q000008:administration & dosage
D011344:Procarbazine; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone